Literature DB >> 15813947

Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice.

P D Skoubis1, H A Lam, J Shoblock, S Narayanan, N T Maidment.   

Abstract

The aversive response to naloxone administration observed in human and animal studies suggests the presence of an endogenous opioid tone regulating hedonic state but the class(es) of opioid peptides mediating such opioid hedonic tone is uncertain. We sought to address this question using mice deficient in either beta-endorphin or pro-enkephalin in a naloxone-conditioned place aversion paradigm. Mice received saline in the morning in one chamber and either saline or naloxone (0.1, 1 or 10 mg/kg, s.c.) in the afternoon in another chamber, each day for 3 days. On the test day they were given free access to the testing chambers in the afternoon and the time spent in each chamber was recorded. Whereas wild-type and beta-endorphin-deficient mice exhibited a robust conditioned place aversion to naloxone, pro-enkephalin knockout mice failed to show aversion to naloxone at any dose tested. In contrast, these mice showed a normal conditioned aversion to the kappa opioid receptor agonist, U50,488 (5 mg/kg), and to LiCl (100 mg/kg) indicating that these mice are capable of associative learning. In a separate experiment, pro-enkephalin knockout mice, similar to wild-type and beta-endorphin-deficient mice, demonstrated a significant conditioned place preference to morphine (2.5, 5 and 10 mg/kg s.c.). These data suggest that enkephalins, but not endorphins, may mediate an endogenous opioid component of basal affective state and also indicate that release of neither endogenous enkephalins nor endorphins is critical for the acquisition or expression of the association between contextual cues and the rewarding effect of exogenously administered opiates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15813947     DOI: 10.1111/j.1460-9568.2005.03956.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  34 in total

Review 1.  Non-nociceptive roles of opioids in the CNS: opioids' effects on neurogenesis, learning, memory and affect.

Authors:  Cherkaouia Kibaly; Chi Xu; Catherine M Cahill; Christopher J Evans; Ping-Yee Law
Journal:  Nat Rev Neurosci       Date:  2019-01       Impact factor: 34.870

2.  Differential involvement of endogenous opioids in sucrose consumption and food reinforcement.

Authors:  Michael D Hayward; Alexandra Schaich-Borg; John E Pintar; Malcolm J Low
Journal:  Pharmacol Biochem Behav       Date:  2006-12-12       Impact factor: 3.533

3.  Peptidomics of Cpefat/fat mouse hypothalamus and striatum: effect of chronic morphine administration.

Authors:  Fabien M Décaillot; Fa-Yun Che; Lloyd D Fricker; Lakshmi A Devi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

4.  Restricted role of CRF1 receptor for the activity of brainstem catecholaminergic neurons in the negative state of morphine withdrawal.

Authors:  Juan-Antonio Garcia-Carmona; Pilar Almela; Alberto Baroja-Mazo; M Victoria Milanes; M Luisa Laorden
Journal:  Psychopharmacology (Berl)       Date:  2011-09-21       Impact factor: 4.530

5.  Cocaine dysregulates opioid gating of GABA neurotransmission in the ventral pallidum.

Authors:  Yonatan M Kupchik; Michael D Scofield; Kenner C Rice; Kejun Cheng; Bernard P Roques; Peter W Kalivas
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

6.  Enkephalin downregulation in the nucleus accumbens underlies chronic stress-induced anhedonia.

Authors:  Jean-François Poulin; Sylvie Laforest; Guy Drolet
Journal:  Stress       Date:  2013-10-31       Impact factor: 3.493

7.  Kappa Opioid Receptor-Mediated Disruption of Novel Object Recognition: Relevance for Psychostimulant Treatment.

Authors:  Jason J Paris; Kate J Reilley; Jay P McLaughlin
Journal:  J Addict Res Ther       Date:  2011-12-24

Review 8.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

9.  Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects.

Authors:  M Ellgren; A Artmann; O Tkalych; A Gupta; H S Hansen; S H Hansen; L A Devi; Y L Hurd
Journal:  Eur Neuropsychopharmacol       Date:  2008-11       Impact factor: 4.600

10.  Disruption of endogenous opioid activity during instrumental learning enhances habit acquisition.

Authors:  K M Wassum; I C Cely; N T Maidment; B W Balleine
Journal:  Neuroscience       Date:  2009-07-18       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.